Akadeum Life Sciences key facts
as of Oct 2026- Developer of bio-separation products designed to facilitate the removal of target cells from biological samples.
- Akadeum Life Sciences is valued at approximately $32.7M as of Oct 2026 (last reported valuation).
- It has raised $55.4M across 6 recorded rounds; the latest was Early Stage VC ($5.6M) in Apr 2025.
- Notable investors include US National Science Foundation, Western Technology Investment, Hemisphere Ventures, Michigan Rise, Invest Detroit Ventures — 36 tracked in total.
- Akadeum Life Sciences has filed 12 Form Ds with the SEC since 2014, most recently Apr 2025 ($5.6M sold to 35 investors).
- Status: Privately Held (backing).
Akadeum Life Sciences's last reported valuation, Sep 2021. Nothing priced has surfaced since.
- ·The complete investor list: 36 names
- ·Watch Akadeum Life Sciences: the Monday email on marks, rounds and moves
Akadeum Life Sciences funding rounds
6 roundsWho backs Akadeum Life Sciences
36+Akadeum Life Sciences valuation
Akadeum Life Sciences's last reported valuation was $32.7 million in Sep 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Akadeum Life Sciences raised?
Akadeum Life Sciences has raised $55.4 million in total; 6 of its rounds are on record, from 2015 on. The largest on record was a $905,063 seed round in May 2015; the most recent was a $5.6 million early-stage round in Apr 2025.
Akadeum Life Sciences has filed 12 Form Ds with the SEC since 2014, most recently in Apr 2025 ($5.6 million sold to 35 investors).
Akadeum Life Sciences investors
36 investors are on record for Akadeum Life Sciences, including US National Science Foundation, Western Technology Investment, Hemisphere Ventures and Michigan Rise. By type, the record holds 9 venture capital firms and 1 angel investor. The early-stage round in Apr 2025 drew 35 investors.
About Akadeum Life Sciences
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2014
- Employees
- 24
- Website
- akadeum.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.